Uni Of Michigan Health System

Ann Arbor, Michigan 48109

3 studies enrolling now · 4 studies all time

What they study most

Advanced Malignancies, Diffuse Cutaneous Systemic Sclerosis, Hematologic Malignancy, Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Prostatic Neoplasms, Solid Tumor

Studies at this site

• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• An Extension Study for Patients Previously Enrolled in Studies With Pelabresib — Recruiting now
• CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Running, not enrolling